52 related articles for article (PubMed ID: 31977081)
1. Physician and facility drivers of spending variation in locoregional prostate cancer.
Rodin D; Chien AT; Ellimoottil C; Nguyen PL; Kakani P; Mossanen M; Rosenthal M; Landrum MB; Sinaiko AD
Cancer; 2020 Apr; 126(8):1622-1631. PubMed ID: 31977081
[TBL] [Abstract][Full Text] [Related]
2. Effects of physician payment reform on provision of home dialysis.
Erickson KF; Winkelmayer WC; Chertow GM; Bhattacharya J
Am J Manag Care; 2016 Jun; 22(6):e215-23. PubMed ID: 27355909
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
4. Physician trajectories of abandoning long-course breast radiotherapy and their cost impact.
Xu X; Soulos PR; Herrin J; Wang SY; Pollack CE; Evans SB; Yu JB; Gross CP
Health Serv Res; 2021 Jun; 56(3):497-506. PubMed ID: 33070305
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse.
Ellis SD; Nielsen ME; Carpenter WR; Jackson GL; Wheeler SB; Liu H; Weinberger M
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):173-81. PubMed ID: 25849354
[TBL] [Abstract][Full Text] [Related]
7. Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.
Davis K; Bellini P; Hagerman C; Zinar R; Leigh D; Hoffman R; Aaronson D; Van Den Eeden S; Philips G; Taylor K
Urology; 2017 Sep; 107():86-95. PubMed ID: 28454988
[TBL] [Abstract][Full Text] [Related]
8. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer.
Jagsi R; Ward KC; Abrahamse PH; Wallner LP; Kurian AW; Hamilton AS; Katz SJ; Hawley ST
Cancer; 2018 Sep; 124(18):3668-3676. PubMed ID: 30033631
[TBL] [Abstract][Full Text] [Related]
9. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144
[TBL] [Abstract][Full Text] [Related]
10. Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer.
Hu X; Lipscomb J; Jiang C; Graetz I
J Natl Cancer Inst; 2023 Mar; 115(3):268-278. PubMed ID: 36583540
[TBL] [Abstract][Full Text] [Related]
11. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
Delaney RK; Sisco-Taylor BL; Wang X; Scherr K; Ubel PA; Haaland B; Kahn VC; Hamstra D; Wei JT; Madanay F; Davis JK; Greeno TU; Fagerlin A
Urology; 2022 Nov; 169():156-161. PubMed ID: 35768027
[TBL] [Abstract][Full Text] [Related]
12. Variation in content discussed by specialty in consultations for clinically localized prostate cancer.
Friedrich NA; Luu M; Gale R; Chaplin A; Ballas L; Sandler HM; Posadas EM; Freedland SJ; Spiegel B; Kokorowski P; Daskivich TJ
Urol Oncol; 2024 Sep; 42(9):288.e7-288.e15. PubMed ID: 38762384
[TBL] [Abstract][Full Text] [Related]
13. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019.
Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
[TBL] [Abstract][Full Text] [Related]
14. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.
Keating NL; Huskamp HA; Schrag D; McWilliams JM; McNeil BJ; Landon BE; Chernew ME; Normand ST
Med Care; 2018 Jan; 56(1):69-77. PubMed ID: 29135615
[TBL] [Abstract][Full Text] [Related]
15. Association Between Urologist Merit-Based Incentive Payment System Performance and Quality of Prostate Cancer Care.
Maganty A; Kaufman SR; Oerline MK; Faraj K; Caram MEV; Shahinian VB; Hollenbeck BK
Urol Pract; 2024 Jan; 11(1):207-214. PubMed ID: 37748132
[TBL] [Abstract][Full Text] [Related]
16. Facility-Level Variation in Use of Locoregional Therapy for Metastatic Prostate Cancer.
Buck M; Ghiraldi E; Demkowicz P; Park HS; An Y; Kann BH; Yu JB; Sprenkle PC; Kim IY; Leapman MS
Urol Pract; 2022 Mar; 9(2):140-149. PubMed ID: 37145694
[TBL] [Abstract][Full Text] [Related]
17. Impact of socioeconomic adjustment on physicians' relative cost of care.
Timbie JW; Hussey PS; Adams JL; Ruder TW; Mehrotra A
Med Care; 2013 May; 51(5):454-60. PubMed ID: 23552439
[TBL] [Abstract][Full Text] [Related]
18. US practice adoption of patient-engagement strategies and spending for adults with diabetes and cardiovascular disease.
Rodriguez HP; Rubio K; Miller-Rosales C; Wood AJ
Health Aff Sch; 2023 Jul; 1(1):qxad021. PubMed ID: 38770409
[TBL] [Abstract][Full Text] [Related]
19. Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Sanoff HK; Lund JL
Oncologist; 2020 Jan; 25(1):46-54. PubMed ID: 31611329
[TBL] [Abstract][Full Text] [Related]
20. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer.
Paravati AJ; Boero IJ; Triplett DP; Hwang L; Matsuno RK; Xu B; Mell LK; Murphy JD
J Oncol Pract; 2015 Sep; 11(5):403-9. PubMed ID: 26265172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
